These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24367515)

  • 1. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting.
    Selden C; Spearman CW; Kahn D; Miller M; Figaji A; Erro E; Bundy J; Massie I; Chalmers SA; Arendse H; Gautier A; Sharratt P; Fuller B; Hodgson H
    PLoS One; 2013; 8(12):e82312. PubMed ID: 24367515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.
    Desille M; Mahler S; Seguin P; Mallédant Y; Frémond B; Sébille V; Bouix A; Desjardins JF; Joly A; Desbois J; Lebreton Y; Campion JP; Clément B
    Crit Care Med; 2002 Mar; 30(3):658-63. PubMed ID: 11990930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver.
    Pasqua M; Pereira U; Messina A; de Lartigue C; Vigneron P; Dubart-Kupperschmitt A; Legallais C
    Tissue Eng Part A; 2020 Jun; 26(11-12):613-622. PubMed ID: 31914890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure.
    Lee JH; Lee DH; Lee S; Kwon CHD; Ryu JN; Noh JK; Jang IK; Park HJ; Yoon HH; Park JK; Kim YJ; Kim SK; Lee SK
    Sci Rep; 2017 Jun; 7(1):3804. PubMed ID: 28630420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.
    Selden C; Bundy J; Erro E; Puschmann E; Miller M; Kahn D; Hodgson H; Fuller B; Gonzalez-Molina J; Le Lay A; Gibbons S; Chalmers S; Modi S; Thomas A; Kilbride P; Isaacs A; Ginsburg R; Ilsley H; Thomson D; Chinnery G; Mankahla N; Loo L; Spearman CW
    Sci Rep; 2017 Nov; 7(1):14518. PubMed ID: 29109530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.
    Weng J; Han X; Zeng F; Zhang Y; Feng L; Cai L; Liang K; Liu S; Li S; Fu G; Zeng M; Gao Y
    Theranostics; 2021; 11(16):7620-7639. PubMed ID: 34335954
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of fulminant hepatic failure porcine plasma supplemented with essential components on encapsulated rat hepatocyte spheroids.
    Lee JH; Lee DH; Park JK; Kim SK; Kwon CH; Lee SK
    Transplant Proc; 2012 May; 44(4):1009-11. PubMed ID: 22564611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting serum-free hepatocyte cryopreservation stage and storage temperature for the application of an "off-the-shelf" bioartificial liver system.
    Lee JH; Park HJ; Kim YA; Lee DH; Noh JK; Jung JG; Yang MS; Lee JE; Lee SH; Yoon HH; Lee SK; Lee S
    Sci Rep; 2024 May; 14(1):12168. PubMed ID: 38806510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model.
    Chen Z; Ding Y; Xu Q; Yu D
    Artif Organs; 2003 Jul; 27(7):613-22. PubMed ID: 12823416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of alginate type and bead diameter on mass transfers and the metabolic activities of encapsulated C3A cells in bioartificial liver applications.
    Gautier A; Carpentier B; Dufresne M; Vu Dinh Q; Paullier P; Legallais C
    Eur Cell Mater; 2011 Jan; 21():94-106. PubMed ID: 21267945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in cell sources of hepatocytes for bioartificial liver.
    Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.
    Erro E; Bundy J; Massie I; Chalmers SA; Gautier A; Gerontas S; Hoare M; Sharratt P; Choudhury S; Lubowiecki M; Llewellyn I; Legallais C; Fuller B; Hodgson H; Selden C
    Biores Open Access; 2013 Feb; 2(1):1-11. PubMed ID: 23514704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
    Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
    Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system.
    Abrahamse SL; van de Kerkhove MP; Sosef MN; Hartman R; Chamuleau RA; van Gulik TM
    Int J Artif Organs; 2002 Oct; 25(10):966-74. PubMed ID: 12456038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evaluation of a new bioartificial liver system in vitro and in vitro.
    Chen Z; Ding YT
    World J Gastroenterol; 2006 Feb; 12(8):1312-6. PubMed ID: 16534893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma.
    Coward SM; Legallais C; David B; Thomas M; Foo Y; Mavri-Damelin D; Hodgson HJ; Selden C
    Artif Organs; 2009 Dec; 33(12):1117-26. PubMed ID: 20078562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage temperatures for cold-chain delivery in cell therapy: a study of alginate-encapsulated liver cell spheroids stored at -80°c or -170°c for up to 1 year.
    Massie I; Selden C; Hodgson H; Fuller B
    Tissue Eng Part C Methods; 2013 Mar; 19(3):189-95. PubMed ID: 22834979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
    van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.